Basis of Presentation and Significant Accounting Policies [Text Block]

. Summary of Significant Accounting Policies

Principles of Consolidation.

The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc., its special-purpose wholly-owned subsidiary, Crucible Intellectual Property, and Liquidmetal Golf. All intercompany balances and transactions have been eliminated.

Non-Controlling Interest.

The results of operations attributable to the non-controlling interest of Liquidmetal Golf are presented within equity and are shown separately from the Company’s equity.

Revenue Recognition

. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic

605

(“ASC

605”),

Revenue Recognition. ASC

605

summarizes certain points of the SEC staff’s views in applying generally accepted accounting principles to revenue recognition in financial statements and provides guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry.

The Company’s revenue recognition policy complies with the requirements of ASC

605.

Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal molds and bulk alloys, licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.

License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted

may

be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are

one

time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Cash.

The Company considers all highly liquid investments with maturity dates of

three

months or less when purchased to be cash equivalents. The Company limits the amount of credit exposure to each individual financial institution and places its temporary cash into investments of high credit quality with a financial institution that exceeds federally insured limits. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of

December

31,

2016

and

2015,

the Company held no deposits in such highly liquid investments.

Trade Accounts Receivable.

The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of

December

31,

2016,

two

customers represented

100%,

$95,

of the total outstanding trade accounts receivable. As of

December

31,

2015,

three

customers represented

100%,

$30,

of the total outstanding trade accounts receivable.

During

2016,

there were

three

major customers, who together accounted for

73%

of total revenue. During

2015,

there were

three

major customers, who together accounted for

52%

of total revenue. During

2014,

there were

four

major customers, who together accounted for

84%

of total revenue. In the future, the Company expects that a significant portion of the revenue

may

continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.

The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the consolidated statements of operations and comprehensive loss. At

December

31,

2016

and

2015,

the Company had not recorded an allowance for doubtful accounts.

Inventory.

Inventory is stated at the lower of weighted-average cost or market. Inventory is recorded at actual cost when purchased and then expensed at weighted-average cost as used in production and/or shipped to satisfy customer orders.

Property and Equipment.

Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from

one

five

years.

Intangible Assets.

Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to register and maintain patents and trademarks. Intangible assets are reported at cost, net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from

ten

seventeen

years.

Impairment of Long-lived Assets

. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset

may

be impaired. These evaluations

may

result from significant decreases in the market price of an asset, a significant adverse change in the extent or manner in which an asset is being used in its physical condition, a significant adverse change in legal factors or in the business climate that could affect the value of an asset, as well as economic or operational analyses. An impairment loss is recognized when the estimated fair value of the assets is less than the carrying value of the assets. Based on the Company’s review of both qualitative and quantitative factors no significant indicators of impairment were identified during the years ended

December

31,

2016,

2015,

and

2014,

respectively.

Fair Value

Measurements.

The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, restricted cash, and short-term debt approximate their carrying value due to their short maturities and are classified as Level

instruments within the fair value hierarchy.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level

—

Quoted prices in active markets for identical assets or liabilities;

Level

—

Observable inputs other than Level

prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level

—

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level

measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic

480

10,

FASB ASC Paragraph

815

and FASB ASC Subparagraph

815

addressing the accounting for certain financial instruments with characteristics of both liabilities and equity and derivative accounting. The fair value of such instruments is estimated using the Black-Scholes option pricing model. Due to the presence of certain anti-dilution and exercise price reset provisions, such instruments are required to be classified as liabilities (see notes

and

12).

As of

December

31,

2016,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		2,224		-		2,224		-
Warrant liabilities (long-term)		2,047		-		2,047		-

As of

December

31,

2015,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		-		-		-		-
Warrant liabilities (long-term)		59		-		59		-

Research and Development Expenses.

Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred.

Advertising and Promotion Expenses.

Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were

$83,

$76

and

$252,

for the years ended

December

31,

2016,

2015

and

2014,

respectively.

Legal Costs.

Legal costs are expensed as incurred.

Stock-Based Compensation

. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic

718,

Share-based Payment

, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values. The fair value of stock options is calculated by using the Black-Scholes option pricing formula that requires estimates for expected volatility, expected dividends, the risk-free interest rate and the term of the option. If any of the assumptions used in the Black-Scholes model change significantly, share-based compensation expense

may

differ materially in the future from that recorded in the current period.

Income Taxes.

Income taxes are provided under the asset and liability method as required by FASB ASC Topic

740,

Accounting for Income Taxes

. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. The effect of a tax rate change on deferred taxes is recognized in operations in the period that the change in the rate is enacted. Valuation allowances are established when necessary to reduce net deferred tax assets to the amount expected to be realized.

Under the provisions of FASB ASC Topic

740,

the Company had no material unrecognized tax positions and no adjustments to liabilities or operations were required. The Company, when applicable, will recognize interest and penalties related to uncertain tax positions in income tax expense. There was no expense related to interest and penalties for the years ended

December

31,

2016,

2015

and

2014,

respectively.

Earnings Per Share.

Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Use of Estimates.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt, and warrant valuations.

Subsequent Events.

The Company evaluated subsequent events through the filing of its Annual Report on Form

-K with the SEC.

Supplemental Cash Flow Information.

Cash payments for interest were

$9,

$4,

and

in the years ended

December

31,

2016,

2015,

and

2014,

respectively.

Recent Accounting Pronouncements.

Leases

February

2016,

the FASB issued an accounting standards update which modifies the accounting for leasing arrangements, particularly those arrangements classified as operating leases. This update will require entities to recognize the assets and liabilities arising from operating leases on the balance sheet. This guidance is effective for fiscal and interim periods beginning after

December

15,

2018

and is required to be applied retrospectively to all leasing arrangements. The Company is currently assessing the effects this guidance

may

have on its consolidated financial statements.

Stock-Based Compensation

March

2016,

the FASB issued an accounting standards update which simplifies the accounting for share-based payment transactions, inclusive of income tax accounting and disclosure considerations. This guidance is effective for fiscal and interim periods beginning after

December

15,

2016

and is required to be applied retrospectively to all impacted share-based payment arrangements. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Revenue from Contracts with Customers

May

2014,

the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective for fiscal and interim periods beginning after

December

15,

2017

and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance

may

have on its consolidated financial statements.

Ability to Continue as a Going Concern

August

2014,

the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after

December

15,

2016,

and for annual periods and interim periods thereafter. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.

Inventory

July

2015,

the FASB issued an accounting standards update which modifies the requirements for measuring the value of inventory on a periodic basis. The new requirement will be to measure inventory at the lower of cost or net realizable value. This standard is effective for the fiscal years beginning after

December

15,

2016,

and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 3 - Significant Transactions	12 Months Ended
Note 3 - Significant Transactions	Dec. 31, 2016
Notes to Financial Statements
Significant Transactions [Text Block]	3 . Significant Transactions 2016 Purchase Agreement On March 10, 2016, the Company entered into a Securities Purchase Agreement (the “2016 Purchase Agreement”) with Liquidmetal Technology Limited, a Hong Kong company (the “Investor”) which provided for the purchase by the Investor of 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. The transaction occurred in multiple closings, with the Investor having purchased 105,000,000 shares at an aggregate purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016 and the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 on October 26, 2016. In addition to the shares issuable under the 2016 Purchase Agreement, the Company issued to the Investor a warrant to acquire 10,066,809 shares of common stock ( of which 2,609,913 of the warrant vested on March 10, 2016 and the remaining 7,456,896 warrant shares vested on October 26, 2016 an exercise price of $0.07 per share). The warrant will expire on the tenth anniversary of its issuance date. Further, the 2016 Purchase Agreement provided that the Investor would have the right to designate three members of the Company’s board of directors with one such member serving as Chairman. The 2016 Purchase Agreement also provided that, with certain limited exceptions, if the Company issues any shares of common stock at any time through the fifth anniversary of the Purchase Agreement, the Investor will have a preemptive right to subscribe for and to purchase at the same price per share (or at market price, in the case of issuance of shares pursuant to stock options) the number of shares necessary to maintain its ownership percentage of Company-issued shares of common stock. Eontec License Agreement On March 10, 2016, in connection with the 2016 Purchase Agreement, the Company and DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec entered into a cross-license of their respective technologies. The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, under the License Agreement, the Company granted to Eontec a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of North America and Europe, and Eontec granted to the Company a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion of the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, North Korea, Philippines, Singapore, South Korea, Thailand and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories. Beyond the License Agreement, the Company collaborates with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not limited to developing technologies to reduce the cost of amorphous alloys, working on die cast machine technology platforms to pursue broader markets, sharing knowledge to broaden our intellectual property portfolio, and utilizing Eontec ’s volume production capabilities as a third party contract manufacturer. 201 4 Purchase Agreement On August 20, 2014, the Company entered into a common stock purchase agreement (“2014 Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital would be committed to purchase up to an aggregate of $30,000 worth of the Company’s common stock, $0.001 par value, over the 36 -month term of the 2014 Purchase Agreement. On March 9, 2016, the Company terminated the 2014 Purchase Agreement. As of the date of termination, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share. Line of Credit Facility In February 2015, the Company entered into a $2,000 line of credit facility, with a fixed interest rate of 2.1%, which originally matured on February 13, 2016. The facility was extended through August 25, 2016, with reductions in available borrowings and associated collateral requirements to $1,000. On August 26, 2016, the Company fully repaid all outstanding principal and accrued interest balances due under the facility. As of such date, all collateral to the facility was released. Interest expense applicable to these borrowings was $9 for the year ended December 31, 2016, and $4 for the year ended December 31, 2015. 2013 Stock Purchase Agreement On November 8, 2013, the Company entered into a Common Stock Purchase Agreement (the “2013 Purchase Agreement”) with certain investors that provided that the investors would purchase up to $20,000 worth of the Company’s common stock over a 36 -month term. In consideration for the execution and delivery of the 2013 Purchase Agreement, on November 8, 2013, the Company issued 2,666,667 shares of common stock to the investors. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014. As of the date of termination, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. July 2012 Private Placement On July 2, 2012, the Company entered into a private placement transaction (the “July 2012 Private Placement”) pursuant to which the Company issued $12,000 in principal amount of senior convertible notes that were due on September 1, 2013. The notes were convertible into shares of the Company’s common stock at a conversion price of $0.352 per share. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012. As of July 17, 2013, the Company had issued 163,641,547 shares of common stock in full satisfaction of the notes (see note 14). As a part of the July 2012 Private Placement, the Company issued warrants to purchase 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share (reduced to $0.17 per share under the anti-dilution and price reset provisions of the warrants). All of the warrants will expire on July 2, 2017 (see note 11). Apple License Transaction On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property that it developed through February 2012. Subsequently, this obligation was extended to apply to all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction. Visser Precision Cast, LLC License Agreement On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. On May 20, 2014, the Company and Visser entered into a settlement agreement significantly amending the Visser MTA, whereby the Company granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 (the “Effective Date”). Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement. In addition, the settlement amended and restated the two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. The amended and restated warrant agreement includes the effect of anti-dilution adjustments and is exercisable for 21,317,094 shares at an exercise price of $0.16 per share under the anti-dilution provisions of the warrants (see Note 11). Other License Transactions On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel. On December 6, 2013, the companies entered into an Exclusivity Agreement for a 10 year term whereby the Company agreed, with certain exceptions and limitations, that the Company and its licensees would purchase amorphous alloy injection molding machines exclusively from Engel in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines. The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf. In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”). Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including the Company), but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Note 4 - Trade Accounts Receivable

12 Months Ended

Dec. 31, 2016

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

. Trade accounts receivable

Trade accounts receivable were comprised of the following:

	December 31,
	2016		2015
Trade accounts receivable	$	95	$	30
Less: Allowance for doubtful accounts		-		-
Trade accounts receivable, net	$	95	$	30

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

Note 7 - Property and Equipment

12 Months Ended

Dec. 31, 2016

Property, Plant and Equipment Disclosure [Text Block]

. Property and Equipment

Property and equipment consist of the following:

	December 31,
	2016			2015

Machinery and equipment	$	2,725		$	2,545
Computer equipment		236			218
Office equipment, furnishings, and improvements		564			564
Total		3,525			3,327
Accumulated depreciation		(2,386	)		(1,957	)
Total property and equipment, net	$	1,139		$	1,370

Depreciation expense for the years ended

December

31,

2016,

2015

and

2014

was

$429,

$423,

and

$197,

respectively. For the year ended

December

31,

2016,

$20

of depreciation expense was included in cost of sales and

$409

was included in selling, marketing, general and administrative expenses. For the year ended

December

31,

2015,

$29

of depreciation expense was included in cost of sales and

$394

was included in selling, marketing, general and administrative expenses. For the year ended

December

31,

2014,

of depreciation expense was included in cost of sales and

$197

was included in selling, marketing, general and administrative expenses.

Note 8 - Patents and Trademarks, Net

12 Months Ended

Dec. 31, 2016

Intangible Assets Disclosure [Text Block]

Patents and trademarks, net

Patents and trademarks consist of the following:

	December 31,
	2016			2015

Purchased and licensed patent rights	$	566		$	566
Internally developed patents		1,686			1,664
Trademarks		148			148
Total		2,400			2,378
Accumulated amortization	$	(1,906	)	$	(1,808	)
Total intangible assets, net	$	494		$	570

Amortization expense was

$98,

$99,

and

$104

for the years ended

December

31,

2016,

2015,

and

2014,

respectively, and is included in research and development expense in the consolidated statements of operations and comprehensive loss. The estimated aggregate amortization expense for each of the

five

succeeding years is as follows:

December 31,	Aggregate Amortization Expense
2017		$	86
2018			86
2019			84
2020			81
2021			56
Thereafter			101
		$	494

Accumulated amortization for the years ended

December

31,

2016

and

2015

is as follows:

	December 31,
	2016			2015

Purchased and licensed patent rights	$	(534	)	$	(517	)
Internally developed patents		(1,253	)		(1,177	)
Trademarks		(119	)		(114	)
Total	$	(1,906	)	$	(1,808	)

The weighted average amortization periods for the years ended

December

31,

2016

and

2015

are as follows:

	December 31,
	2016		2015

Purchased and licensed patent rights		17		17
Internally developed patents		17		17
Trademarks		10		10

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreements.

In addition to the purchased and licensed patents, the Company has capitalized legal and registration costs incurred to obtain and maintain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

Note 9 - Short-term Debt	12 Months Ended
Note 9 - Short-term Debt	Dec. 31, 2016
Notes to Financial Statements
Short-term Debt [Text Block]	9. Short-Term Debt Short-term debt totaled $0 and $700 as of December 31, 2016 and December 31, 2015, respectively, and consisted of borrowings under a line of credit facility, with a fixed interest rate of 2.1%. All borrowings were fully repaid upon maturity of the facility on August 26, 2016. Interest expense related to outstanding borrowings was $9, $4, and $0 for the years ended December 31, 2016, 2015, and 2014, respectively. This credit facility required the Company to maintain collateral for the full amount of the facility. Following maturity of the facility all collateral requirements have been removed.

Note 11 - Warrant Liabilities

12 Months Ended

Dec. 31, 2016

Warrant [Member]

Derivatives and Fair Value [Text Block]

. Warrant Liabilities

Pursuant to FASB ASC

815,

the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of warrants.

During

June

2012,

the Company issued warrants to purchase a total of

15,000,000

shares of common stock to Visser under the Visser MTA (see note

3).

These warrants had an original exercise price of

$0.22

per share and expire on

June

2017

and were originally valued at

$4,260.

The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC

815.

As a result of subsequent issuances of the Company’s common stock, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to

$0.16

and

$0.17

as of

December

31,

2016

and

December

31,

2015,

respectively. In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to

21,317,094

and

18,937,931

as of

December

31,

2016

and

December

31,

2015

, respectively. As of

December

31,

2016,

these warrants were valued at

$1,528

using the Black

-Scholes valuation model utilizing the following assumptions: (i) expected life of

0.42

years, (ii) volatility of

82%,

(iii) risk-free interest rate of

0.6%,

and (iv) dividend rate of

The change in warrant value for these warrants for the years ended

December

31,

2016,

2015

and

2014

was a (loss) gain of

($1,494),

$1,019,

and

$1,506,

respectively.

July

2012,

the Company issued warrants to purchase a total of

18,750,000

shares of common stock as part of the

July

2012

Private Placement. These warrants have an exercise price of

$0.384

per share, expire on

July

2017,

and were originally valued at

$5,053.

These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC

815.

As a result of contractually defined price resets, and issuances under the

2013,

2014,

and

2016

Purchase Agreements, which resulted in an anti-dilution impact

, the exercise price of these warrants was reduced to

$0.17

and

$0.19

as of

December

31,

2016

and

December

31,

2015,

respectively

. As of

December

31,

2016

there were warrants to purchase a total of

10,540,750

shares of common stock outstanding, which were valued at

$696

using the Black

-Scholes valuation model utilizing the following assumptions: (i) expected life of

0.50

years, (ii) volatility of

76%,

(iii) risk-free interest rate of

0.6%,

and (iv) dividend rate of

The change in warrant value for these warrants for the years ended

December

31,

2016,

2015

and

2014

was a (loss) gain of

($1,336),

$927,

and

$1,194,

respectively.

March

10,

2016,

the Company issued warrants to purchase a total of

10,066,809

shares of common stock as part of the

2016

Purchase Agreement. These warrants have an exercise price of

$0.07

per share, expire on

March

10,

2026,

and were originally valued at

$760.

These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC

815.

As of

December

31,

2016,

these warrants were valued at

$2,047

under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of

9.19

years, (ii) volatility of

122%,

(iii) risk-free interest rate of

2.5%,

and (iv) dividend rate of

The change in fair value for these warrants for the years ended

December

31,

2016,

2015,

and

2014

was a loss of

$1,287,

$0,

and

$0,

respectively.

During

December

2016

an investor party to the

July

2012

Private Placement exercised, on a cashless basis,

7,031,250

warrants, resulting in the issuance of

1,743,480

shares of the Company’s common stock. Upon exercise, the Company reclassified

$665

of the associated warrant liability to permanent equity, with

being allocated to common stock and

$663

to additional paid in capital.

The following table summarizes the change in the Company’s warrant liabilities for the year ended

December

31,

2016:

	Visser MTA		July 2, 2012			2016 Purchase
	Agreement		Private Placement			Agreement		Total

Beginning Balance - December 31, 2015	$	34	$	25		$	-		59
Original valuation- new issuances	$	-	$	-		$	760		760
Change in value of warrant liability, loss	$	1,494	$	1,336		$	1,287		4,117
Exercises		-		(665	)		-		(665	)
Ending Balance - December 31, 2016	$	1,528	$	696		$	2,047	$	4,271

Included in current liabilities	$	1,528	$	696		$	-	$	2,224
Included in long-term liabilities	$	-	$	-		$	2,047	$	2,047

The Company had warrants to purchase

41,924,653

and

36,509,931

shares of common stock outstanding as of

December

31,

2016

and

December

31,

2015,

respectively, which were valued and classified as liabilities under FASB ASC

815.

The change in fair value of warrants resulted in a total non-cash (loss) gain of

($4,117),

$1,946,

and

$2,700

for the years ended

December

31,

2016,

2015,

and

2014,

respectively.

The fair value of warrants outstanding for the following periods was computed using the Black-Scholes model under the following assumptions:

	December 31,
	2016			2015
Expected life in years	0.42	-	9.19	1.42	-	1.50
Volatility	76%	-	122%	56%	-	57%
Risk-free interest rate	0.6%	-	2.5%		1.1%
Dividend rate		0%			0

As of

December

31,

2016,

outstanding warrants to acquire shares of the Company’s common stock are as follows:

Number of Shares	Exercise Price		Expiration Date

21,317,094	$	0.16	June 1, 2017
10,540,750	$	0.17	July 2, 2017
10,066,809	$	0.07	March 10, 2026
41,924,653

Note 12 - Option Liabilities

12 Months Ended

Dec. 31, 2016

Call Option [Member]

Derivatives and Fair Value [Text Block]

Option Liabilities

As part of the

2016

Purchase Agreement, the Company granted the Investor the right to purchase shares of the Company’s common stock in the future at predetermined prices. These options allowed the Investor to purchase

200,000,000

shares of the Company’s common stock at a price of

$0.15

per share and

100,000,000

shares of the Company’s common stock at a price of

$0.25

per share. Given that the number of shares to be issued upon exercise of these options was in excess of the number of shares authorized for issuance, these options were originally required to be classified as liabilities under FASB ASC

815.

The

200,000,000

share option and the

100

,000,000

share option were initially valued at

$489

and

$22,

respectively. Following the filing of an amendment to the Company’s Certificate of Incorporation, which allowed for adequate authorized shares, these options were revalued as of

May

19,

2016

and reclassified to permanent shareholders’ equity. On

May

19,

2016,

the

200,000,000

share option and the

100

,000,000

share option were valued at

$2,931

and

$193,

respectively, under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of

0.25

years, (ii) volatility of

85%,

(iii) risk-free interest rate of

0.31%,

and (iv) dividend rate of

The change in fair value for these options was a loss of

$2,442

and

$171,

respectively, for the year ended

December

31,

2016.

The following table summarizes the change in the Company’s option liabilities as of

December

31,

2016:

	200M Share			100M Share
	Call Option			Call Option			Total

Beginning Balance - December 31, 2015	$	-		$	-			-
Original valuation		489			22			511
Change in value of option liabilities, loss		2,442			171			2,613
Reclassification to shareholders' equity		(2,931	)		(193	)		(3,124	)
Ending Balance - December 31, 2016		-			-			-

August

11,

2016,

the Company and the Investor entered into an amendment to the

2016

Purchase Agreement. Under the amendment, the Company agreed to extend the deadline for the Investor’s purchase of

300,000,000

additional shares of Company common stock under the

2016

Purchase Agreement from the original deadline of

August

17,

2016

to a new deadline of

December

31,

2016.

Other than the extension of the deadline, the amendment did not materially modify the terms of the

2016

Purchase Agreement. As a result of this amendment the Company recorded an additional

$2,126

of expense to additional paid in capital. Such amount is reflected as a loss on contract modification within the consolidated statements of operations and comprehensive loss

. On

October

26,

2016,

the Investor fully exercised these options through the purchase of

300,000,000

shares of the Company’s common stock.

Note 14 - Shareholders' Equity (Deficit)	12 Months Ended
Note 14 - Shareholders' Equity (Deficit)	Dec. 31, 2016
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	1 4 . Shareholders’ Equity ( Defici t) Common stock In June 2012, the Company issued 30,000,000 shares of common stock to Visse r in connection with the Visse r MTA (see note 3). Pursuant to the terms of the Company’s Senior Convertible Notes issued in the July 2012 Private Placement, the Company opted to pay the twelve monthly installment payments prior to the September 1, 2013 maturity date with shares of the Company’s common stock. Upon final settlement, the Company had issued 163,641,547 shares of common stock at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 principal and $680 of interest (see note 3). During the year ended December 31, 2013, the holders of the Company’s Series A Preferred Stock converted all of the outstanding 506,936 shares of preferred stock into 16,896,070 shares of the Company’s common stock (see “Preferred stock” below). After giving effect to such conversion, the Company has no shares of preferred stock outstanding. On February 28, 2013, the Company’s shareholders approved an amendment to the Certificate of Incorporation of the Company increasing the number of authorized shares of common stock from 400 million shares to 500 million shares. On October 24, 2013, the Company’s shareholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 500 million shares to 700 million shares . In connection with the execution of the 2013 Purchase Agreement, the Company issued to certain investors 2,666,667 shares of the Company’s common stock. As of December 31, 2014, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014 (see Note 3). On September 9, 2014, an initial registration statement covering 75,000,000 shares issued and issuable pursuant to the 2014 Purchase Agreement was declared effective by the SEC. As of September 30, 2015, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share. On March 8, 2016, the Company voluntarily terminated the 2014 Purchase Agreement, effective March 9, 2016 (see Note 3). In connection with the execution of the 2016 Purchase Agreement , on March 10, 2016, the Company issued 105,000,000 shares of the Company’s common stock, at a price of $0.08 per share, for gross proceeds of $8,400. On May 19, 2016, the Company’s shareholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 700 million shares to 1,100 million shares. On October 26, 2016, the Company issued and sold to the Investor of the 2016 Purchase Agreement an aggregate of 300,000,000 shares of Company’s common stock for an aggregate purchase price of $55,000, comprised of 200,000,000 shares at a price of $0.15 per share and 100,000,000 shares at a price of $0.25 per share. In 2012, the Company entered into a non-exclusive engagement agreement with an investment banking firm. The services provided by the firm did not result in the identification of any practicable investment transactions and the agreement was considered effectively terminated by the Company in 2013. During 2016, the Company was notified by a representative of the firm stipulating that it did not consider the engagement agreement to be terminated and that previous financings and other funding transactions completed by the Company may be subject to success fees. In November 2016, the Company reached a settlement with respect to any and all amounts allegedly due under the engagement agreement in the amount of $750. Such amounts have been reflected as a reduction of current year proceeds from stock issuances and a corresponding reduction to additional paid in capital. Warrants In connection with the Series A Preferred Stock issuances in 2009, warrants to purchase 29,779,557 shares of the Company’s common stock, valued at $18,179, were outstanding through July 15, 2015. Due to extension of the expiration date of these warrants during 2010, they no longer contained anti-dilution provisions and were reflected as equity as they did not meet the criteria under FASB ASC 815 for liability treatment. Such warrants had exercise prices ranging between $0.48 and $0.49 and expired on July 15, 2015.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

Note 15 - Stock Compensation Plan

12 Months Ended

Dec. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

. Stock Compensation Plan

April

2002,

our shareholders and Board of Directors adopted the

2002

Equity Incentive Plan

(“2002

Plan”). The

2002

Plan provides for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of

10,000,000

shares of our common stock

may

be granted under the

2002

Plan. The

2002

Plan expired by its terms in

April

2012,

but it will remain in effect only with respect to the equity awards that have been granted prior to its expiration. As of

December

31,

2016,

there were

265,000

options outstanding under the

2002

Plan.

June

28,

2012,

the Company adopted the

2012

Equity Incentive Plan

(“2012

Plan”)

, with the approval of the shareholders

, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The

2012

Plan provides for the granting to employees of incentive stock options within the meaning of Section

422

of the Internal Revenue Code of

1986,

as amended, and for the granting to employees and consultants of non

-statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of

30,000,000

shares of the Company’s common stock

may

be granted under the

2012

Equity Incentive Plan, and all options granted under this plan had exercise prices that were equal to the fair market value on the date of grant. During

2016,

the Company granted options to purchase

4,232,734

shares of common stock

, with total options outstanding of

23,947,402

as of

December

31,

2016.

January

27,

2015,

the Company adopted its

2015

Equity Incentive Plan

(“2015

Plan”)

, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries

. A total of

40,000,000

shares of the Company’s common stock are available for issuance under the

2015

Plan

. All options granted under the

2015

Plan had exercise prices that were equal to the fair market value on the dates of grant. During

2016,

the Company granted options to purchase

18,831,667

shares of common stock

, with total options outstanding of

23,370,000

as of

December

31,

2016.

FASB ASC

718,

Compensation – Stock Compensation,

requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under ASC

718,

Company is required to measure the cost of employee services received in exchange for stock options and similar awards based on the grant-date fair value of the award and recognize this cost in the income statement over the period during which an employee is required to provide service in exchange for the award. The Company recorded

$1,694,

$1,557,

and

$1,219

for the years ended

December

31,

2016,

2015,

and

2014,

respectively, of non-cash charges for stock compensation related to amortization of the fair value of restricted stock and unvested stock options. The total compensation costs related to non-vested awards not yet recognized were

$2,639,

$3,904,

and

$3,090

for the years ended

December

31,

2016,

2015,

and

2014,

respectively.

August

2010,

in conjunction with an employment agreement with Thomas Steipp, the Company’s former Chief Executive Officer, the Company also granted an aggregate of

6,000,000

restricted shares of the Company’s common stock, which vested ratably over

five

years. During the years ended

December

31,

2016,

2015,

and

2014,

the Company recorded

$0,

$182,

and

$312,

respectively, of compensation expense related to Mr. Steipp’s restricted shares, which are included in the stock-based compensation totals above.

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions noted in the following table.

	December 31,
	2016			2015			2014

Expected volatility	56.48%	-	115.39%	84.19%	-	168.46%	157.24%	-	179.87%
Expected dividends		-			-			-
Expected term (in years)	1.00	-	6.32	0.73	-	6.32	5.50	-	7.50
Risk-free rate	0.76%	-	2.13%	0.39%	-	1.96%	1.65%	-	2.22%

Expected volatilities are based on historical volatility expected over the expected life of the options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. Forfeiture rates of

8.83%,

5.34%

and

7.01%

were used for options granted during the years ended

December

31,

2016,

2015

and

2014,

respectively. The risk free rate for period within the expected life of the options is based on U.S. Treasury rates in effect at the time of grant.

The following table summarizes the Company’s stock option transactions for the years ended

December

31,

2016

and

2015:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
								(in thousands)
Options outstanding at December 31, 2014		27,540,899			0.21
Granted		20,285,001			0.14
Exercised		(166,666	)		0.08
Forfeited		(4,933,500	)		0.18
Expired		(815,000	)		0.64
Options outstanding at December 31, 2015		41,910,734			0.21
Granted		23,064,401			0.10
Exercised		(2,197,199	)		0.09
Forfeited		(12,931,033	)		0.14
Expired		(2,264,501	)		0.19
Options outstanding at December 31, 2016		47,582,402		$	0.15		7.4	$	3,669
Options exercisable at December 31, 2016		22,419,208		$	0.17		6.1	$	1,504
Options unvested at December 31, 2016		25,163,194		$	0.14		8.5	$	2,165
Options vested or expected to vest at December 31, 2016		44,423,120		$	0.15		7.3	$	3,379

The following table provides supplemental data on stock options for the years ended

December

31,

2016,

2015

and

2014:

	December 31,
	2016		2015		2014

Weighted average grant date fair value per option granted	$	0.08	$	0.12	$	0.28
Fair value of options vested		2,022		1,584		385
Cash from participants to exercise stock options		206		13		205
Intrinsic value of options exercised		221		8		385

The following table summarizes the Company’s stock options outstanding and exercisable by ranges of option prices as of

December

31,

2016:

Options Outstanding									Options Exercisable
Range of Exercise Prices			Numbers of Options Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price

$0.00	-	0.10		20,603,777		7.28	$	0.07		8,132,001		4.97	$	0.08
0.11	-	0.772		26,978,625		7.40		0.21		14,287,207		6.76		0.22

Total				47,582,402						22,419,208

The Company’s non-vested options at the beginning and ending of fiscal year

2016

had weighted-average grant-date fair values of

$0.16

and

$0.13

per option, respectively.

In connection with the separation of former executives and directors, the Company has modified previously granted equity awards to allow for the acceleration or additional vesting of equity awards following the respective separation dates. The Company incurred incremental stock-based compensation expense of

$367,

$13,

and

during the years ended

December

31,

2016,

2015,

and

2014,

respectively.

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

Note 16 - Income Taxes

12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Text Block]

. Income Taxes

Significant components of deferred tax assets are as follows:

	Years Ended December 31,
	2016			2015

Loss carry forwards	$	57,097		$	53,693
Derivative valuations		685			(955	)
NQSO		2,214			1,710
Tax Credits		433			433
Other		(99	)		198
Total deferred tax asset		60,330			55,079

Valuation allowance		(60,330	)		(55,079	)
Total deferred tax asset, net		-			-

The valuation allowance increased

$5,251

and

$131

2016

and

2015,

respectively. The change in deferred tax assets resulted from current year net operating losses and changes to future tax deductions resulting from derivative valuations, the terms of stock compensation plans, and accrued liabilities.

The following table accounts for the differences between the expected federal tax benefit (based on the statutory U.S. federal income tax rate of

34%)

and the actual tax provision:

	Years Ended December 31,
	2016			2015			2014

Expected federal tax benefit		-34.0	%		-34.0	%		-34.0	%
Permanent items		5.6	%		0.4	%		0.1	%
Net operating loss utilized or expired		0.0	%		0.0	%		0.0	%
Increase in valuation allowance and others		28.4	%		33.6	%		33.9	%

Effective tax rate		0	%		0	%		0	%

As of

December

31,

2016,

the Company had approximately

$152.2

million of net operating loss (“NOL”) carryforwards for U.S. federal income tax purposes expiring in

2019

through

2036.

As of

December

31,

2016,

the Company had approximately

$91.5

million of NOL carryforwards for California income tax purposes expiring in

2017

through

2036,

respectively. The Company and Liquidmetal Golf, Inc. file on a separate company basis for federal income tax purposes. Accordingly, the federal NOL carryforwards of

one

legal entity are not available to offset federal taxable income of the other. Liquidmetal Golf, Inc. had approximately

$36.0

million in federal NOL carryforwards, expiring in

2019

through

2036.

We recognize excess tax benefits associated with the exercise of stock options directly to shareholders’ equity only when realized. Accordingly, deferred tax assets are not recognized for NOL carryforwards resulting from excess tax benefits. As of

December

31,

2016,

deferred tax assets do not include approximately

$133

of these tax effected excess tax benefits from employee stock option exercise that are a component of our NOL carryforwards. Accordingly, additional paid-in capital will increase up to an additional

$133

if and when such excess tax benefits are realized.

As of

December

31,

2016,

the Company had approximately

$189

of Research & Development (“R&D”) credit carryforwards for U.S. federal income tax purposes expiring in

2021

through

2030.

In addition, the Company has California R&D credit carryforwards of approximately

$243,

which do not expire under current California law.

Section

382

of the Internal Revenue Code (“IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. As a result of the completion of the complex analysis required by the IRC to determine if an ownership change has occurred, the Company has determined that its annual NOL carryforward limitation under Section

382

of the IRC is

$764

per year.

The ability to realize the tax benefits associated with deferred tax assets, which includes benefits related to NOL’s, is principally dependent upon the Company’s ability to generate future taxable income from operations. The Company has provided a full valuation allowance for its net deferred tax assets due to the Company’s net operating losses.

The Company adopted the provisions of FASB ASC Topic

470

– Income Taxes. At the adoption date and as of

December

31,

2016,

the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense which were

for the years ended

December

31,

2016,

2015

and

2014.

As of

December

31,

2016,

the tax years

2013

through

2015,

and

2011

through

2015

are subject to examination by the federal and California taxing authorities, respectively.

Note 17 - Loss Per Common Share	12 Months Ended
Note 17 - Loss Per Common Share	Dec. 31, 2016
Notes to Financial Statements
Earnings Per Share [Text Block]	1 7 . Loss Per Common Share Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings. Options to purchase 47,582,402 shares of common stock at prices ranging from $0.07 to $0.77 per share were outstanding at December 31, 2016, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 41,910,734 shares of common stock at prices ranging from $0.08 to $1.44 per share were outstanding at December 31, 2015, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 27,540,899 shares of common stock at prices ranging from $0.08 to $2.33 per share were outstanding at December 31, 2014, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 41,924,653 shares of common stock, with prices ranging from $0.07 to $0.17 per share, outstanding at December 31, 2016 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 36,509,931 shares of common stock, with prices ranging from $0.17 to $0.19 per share, outstanding at December 31, 2015 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 66,057,792 shares of common stock, with prices ranging from $0.18 to $0.49 per share, outstanding at December 31, 2014 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

Note 18 - Segment Information	12 Months Ended
Note 18 - Segment Information	Dec. 31, 2016
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	18. Segment Information The primary business of the Company is to develop and manufacture products and applications from amorphous alloys. As a result, the Company’s financial results are reported in a single segment.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

Note 19 - Commitments and Contingencies

12 Months Ended

Dec. 31, 2016

Commitments and Contingencies Disclosure [Text Block]

. Commitments and Contingencies

Alloy Purchase Commitments

As of

December

31,

2016,

the Company has signed firm purchase commitments for alloy supplies that will be delivered over a

thirty

(30)

month period. Total commitments were

$689

as of

December

31,

2016.

Operating Lease

Commitments

The Company leases its offices and warehouse facilities under various lease agreements, certain of which are subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. As of

December

31,

2016

and

2015,

the Company has recorded

$91

and

$72,

respectively, of deferred rent expenses. Future minimum lease payments under non-cancelable operating leases during subsequent years are as follows:

December 31,	Minimum Payments

2017		212
2018		217
2019		242
2020		248
2021		253
Thereafter		346
Total	$	1,518

Rent expense was

$225,

and

$204

for the years ended

December

31,

2016,

2015,

and

2014,

respectively.

Note 20 - 401(k) Savings Plan	12 Months Ended
Note 20 - 401(k) Savings Plan	Dec. 31, 2016
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	20 . 401(k) Savings Plan The Company has a tax-qualified employee savings and retirement plan, or 401(k) plan. Under the 401 (k) plan, participants may elect to reduce their current compensation, on a pre-tax basis, by up to 15% of their taxable compensation or of the statutorily prescribed annual limit, whichever is lower, and have the amount of the reduction contributed to the 401(k) plan. The 401(k) plan permits the Company, in its sole discretion, to make additional employer contributions to the 401(k) plan. However, the Company did not make employer contributions to the 401(k) plan during any of the periods presented in the accompanying consolidated financial statements.

Note 21 - Related Party Transactions	12 Months Ended
Note 21 - Related Party Transactions	Dec. 31, 2016
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	21 . Related Party Transactions The Company entered into a license agreement (the “IMG License Agreement”) with Innovative Materials Group, LLC (“IMG”), a California limited liability company which is majority owned by Mr. Kang, a former Chief Executive Officer and former Chairman of the Company , to license certain patents and technical information for the limited purpose of manufacturing certain licensed products with the Company’s first generation die cast machines. The IMG License Agreement granted a non-exclusive license to certain product categories, as well as an exclusive license to specific types of consumer eyewear products and obligated IMG to pay the Company a running royalty based on its sales of licensed products through August 5, 2021. The Company recognized $ 0, $0, and $6 in royalty revenues from IMG during the years ended December 31, 2016, 2015, and 2014, respectively. The IMG License Agreement was terminated on March 8, 2016. On November 17, 2016, the Company and Thomas Steipp, the former Company’s President and Chief Executive Officer, entered into a Separation and Mutual Release Agreement pursuant to which Mr. Steipp resigned as an officer, director, and employee of the Company (the “Separation Agreement”). The Separation Agreement provides for the payment of severance compensation to Mr. Steipp in the form of a lump sum of $3 00 (subject to tax withholdings) and reimbursement for COBRA healthcare coverage for a period of 12 months. In addition, it provides for the accelerated vesting of 3,990,400 of the 9,939,451 unvested stock options held by Mr. Steipp as of the separation date and the extension of the exercise period of his options until the second anniversary of the date of the Separation Agreement. This results in a total of 10,777,949 stock options being exercisable by Mr. Steipp as of the separation date and resulted in an additional $297 of stock-based compensation expense during the year ended December 31, 2016. In connection with the Separation Agreement, Mr. Steipp and the Company granted each other mutual general releases subject to customary exceptions. As of December 31, 2016, the Company had accrued liabilities totaling $301 relating to the Separation Agreement. In March 2016, the Company entered into amended Change of Control Agreements with certain of its executive officers. The Change of Control Agreements provide that if the executive officer’s employment with the Company is terminated without cause during the one -year period after a change of control of the Company, then the terminated officer will receive lump sum severance compensation in an amount equal to twelve months of his then-current base salary. Under the agreements, each of the executive officers will also be entitled to the above-described severance compensation in the event he terminates his own employment within one year after a change of control because of a salary decrease, assignment to a lower-level position, or a required move of more than twenty - five miles. In addition, upon termination, all unvested stock options related to these officers will automatically and immediately vest and shall thereafter be exercisable in accordance with the terms and provisions of the applicable award agreements. On March 10, 2016, the Company entered into the 2016 Purchase Agreement with Liquidmetal Technology Limited, providing for the purchase of 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. Liquidmetal Technology Limited is a newly formed company owned by Professor Lugee Li (“Professor Li”) . In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and Eontec, entered into a license agreement pursuant to which the Company and Eontec entered into a cross-license of their respective technologies. Eontec is a publicly held Hong Kong corporation of which Professor Li is the Chairman and majority shareholder. As of December 31, 2016, Professor Li is a greater-than 5% beneficial owner of the Company and serves as the Company’s Chairman, President, and Chief Executive Officer . Services procured from Eontec were $68, $0, and $0 during the years ended December 31, 2016, 2015, and 2014, respectively.

Note 23 - Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2016

Quarterly Financial Information [Text Block]

23.

Quarterly Financial Information (Unaudited)

(in thousands, except per share data)

	Quarter Ended
	March 31, 2016			June 30, 2016			September 30, 2016			December 31, 2016			Total

Revenue	$	168		$	34		$	154		$	124		$	480
Gross profit (loss)		10			21			(11	)		(93	)	$	(73	)
Operating loss		(2,566	)		(2,367	)		(2,238	)		(2,716	)	$	(9,887	)
Net loss and comprehensive loss		(9,178	)		(824	)		(3,802	)		(4,948	)	$	(18,752	)
Basic and diluted net loss per common share	$	(0.02	)	$	(0.00	)	$	(0.01	)	$	(0.00	)	$	(0.03	)

	Quarter Ended
	March 31, 2015			June 30, 2015			September 30, 2015			December 31, 2015			Total

Revenue	$	26		$	39		$	42		$	18		$	125
Gross profit (loss)		7			(94	)		(118	)		(19	)	$	(224	)
Operating loss		(2,327	)		(2,440	)		(2,372	)		(2,142	)	$	(9,281	)
Net loss and comprehensive loss		(2,480	)		(2,085	)		(1,230	)		(1,522	)	$	(7,317	)
Basic and diluted net loss per common share	$	(0.01	)	$	(0.01	)	$	(0.00	)	$	(0.00	)	$	(0.02	)

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2016

Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

Valuation and Qualifying Accounts

(in $ thousands)

	Balance at		Additions Charged to							Balance
	Beginning		Costs and		Other					at End
Year ended December 31, 2016	of Period		Expenses		Accounts		Deductions			of Period

Uncollectible accounts		-		-		-		-			-
Deferred tax asset valuation allowance		55,079		6,675		-		(1,424	)		60,330
Total	$	55,079	$	6,675	$	0	$	(1,424	)	$	60,330

Year ended December 31, 2015

Uncollectible accounts		-		19		-		(19	)		-
Deferred tax asset valuation allowance		54,948		4,451		-		(4,320	)		55,079
Total	$	54,948	$	4,470	$	0	$	(4,339	)	$	55,079

Year ended December 31, 2014

Uncollectible accounts		-		-		-		-			-
Deferred tax asset valuation allowance		52,374		2,582		-		(8	)		54,948
	$	52,374	$	2,582	$	0	$	(8	)	$	54,948

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation.

Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]

Non-Controlling Interest.

The results of operations attributable to the non-controlling interest of Liquidmetal Golf are presented within equity and are shown separately from the Company’s equity.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic

605

(“ASC

605”),

Revenue Recognition. ASC

605

The Company’s revenue recognition policy complies with the requirements of ASC

605.

may

be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are

one

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash.

The Company considers all highly liquid investments with maturity dates of

three

December

31,

2016

and

2015,

the Company held

deposits in such highly liquid investments.

Receivables, Policy [Policy Text Block]

Trade Accounts Receivable.

December

31,

2016,

two

customers represented

100%,

$95,

of the total outstanding trade accounts receivable. As of

December

31,

2015,

three

customers represented

100%,

$30,

of the total outstanding trade accounts receivable.

During

2016,

there were

three

major customers, who together accounted for

73%

of total revenue. During

2015,

there were

three

major customers, who together accounted for

52%

of total revenue. During

2014,

there were

four

major customers, who together accounted for

84%

of total revenue. In the future, the Company expects that a significant portion of the revenue

may

continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.

December

31,

2016

and

2015,

the Company had

not

recorded an allowance for doubtful accounts.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment.

one

five

years.

Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]

Intangible Assets.

ten

seventeen

years.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Long-lived Assets

. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset

may

be impaired. These evaluations

may

significant indicators of impairment were identified during the years ended

December

31,

2016,

2015,

and

2014,

respectively.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value

Measurements.

instruments within the fair value hierarchy.

Level

—

Quoted prices in active markets for identical assets or liabilities;

Level

—

Observable inputs other than Level

Level

—

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level

measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic

480

10,

FASB ASC Paragraph

815

and FASB ASC Subparagraph

815

and

12).

As of

December

31,

2016,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		2,224		-		2,224		-
Warrant liabilities (long-term)		2,047		-		2,047		-

As of

December

31,

2015,

the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities (current)		-		-		-		-
Warrant liabilities (long-term)		59		-		59		-

Research and Development Expense, Policy [Policy Text Block]

Research and Development Expenses.

Advertising Costs, Policy [Policy Text Block]

Advertising and Promotion Expenses.

Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were

$83,

$76

and

$252,

for the years ended

December

31,

2016,

2015

and

2014,

respectively.

Legal Costs, Policy [Policy Text Block]

Legal Costs.

Legal costs are expensed as incurred.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock-Based Compensation

. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic

718,

Share-based Payment

may

differ materially in the future from that recorded in the current period.

Income Tax, Policy [Policy Text Block]

Income Taxes.

Income taxes are provided under the asset and liability method as required by FASB ASC Topic

740,

Accounting for Income Taxes

Under the provisions of FASB ASC Topic

740,

expense related to interest and penalties for the years ended

December

31,

2016,

2015

and

2014,

respectively.

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates.

Subsequent Events, Policy [Policy Text Block]

Subsequent Events.

The Company evaluated subsequent events through the filing of its Annual Report on Form

-K with the SEC.

Supplemental Cash Flow Information, Policy [Policy Text Block]

Supplemental Cash Flow Information.

Cash payments for interest were

$9,

$4,

and

in the years ended

December

31,

2016,

2015,

and

2014,

respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements.

Leases

February

2016,

December

15,

2018

and is required to be applied retrospectively to all leasing arrangements. The Company is currently assessing the effects this guidance

may

have on its consolidated financial statements.

Stock-Based Compensation

March

2016,

December

15,

2016

Revenue from Contracts with Customers

May

2014,

December

15,

2017

and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance

may

have on its consolidated financial statements.

Ability to Continue as a Going Concern

August

2014,

December

15,

2016,

and for annual periods and interim periods thereafter. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.

Inventory

July

2015,

December

15,

2016,

and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Inventory, Policy [Policy Text Block]

Inventory.

Note 6 - Inventory (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Inventory, Current [Table Text Block]

	December 31, 2016		December 31, 2015

Raw materials	$	350	$	39
Work in progress		25		-
Finished goods		15		44
Total		390		83

Note 8 - Patents and Trademarks, Net (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	December 31,
	2016			2015

Purchased and licensed patent rights	$	566		$	566
Internally developed patents		1,686			1,664
Trademarks		148			148
Total		2,400			2,378
Accumulated amortization	$	(1,906	)	$	(1,808	)
Total intangible assets, net	$	494		$	570

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

December 31,	Aggregate Amortization Expense
2017		$	86
2018			86
2019			84
2020			81
2021			56
Thereafter			101
		$	494

Finite-lived Intangible Assets, Accumulated Amortization [Table Text Block]

	December 31,
	2016			2015

Purchased and licensed patent rights	$	(534	)	$	(517	)
Internally developed patents		(1,253	)		(1,177	)
Trademarks		(119	)		(114	)
Total	$	(1,906	)	$	(1,808	)

Finite-lived Intangible Assets, Weighted Average Amortization Periods [Table Text Block]

	December 31,
	2016		2015

Purchased and licensed patent rights		17		17
Internally developed patents		17		17
Trademarks		10		10

Note 11 - Warrant Liabilities (Tables)

12 Months Ended

Dec. 31, 2016

Fair Value Assumptions used for Warrants Outstanding [Table Text Block]

	December 31,
	2016			2015
Expected life in years	0.42	-	9.19	1.42	-	1.50
Volatility	76%	-	122%	56%	-	57%
Risk-free interest rate	0.6%	-	2.5%		1.1%
Dividend rate		0%			0

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Number of Shares	Exercise Price		Expiration Date

21,317,094	$	0.16	June 1, 2017
10,540,750	$	0.17	July 2, 2017
10,066,809	$	0.07	March 10, 2026
41,924,653

Warrant [Member]

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

	Visser MTA		July 2, 2012			2016 Purchase
	Agreement		Private Placement			Agreement		Total

Beginning Balance - December 31, 2015	$	34	$	25		$	-		59
Original valuation- new issuances	$	-	$	-		$	760		760
Change in value of warrant liability, loss	$	1,494	$	1,336		$	1,287		4,117
Exercises		-		(665	)		-		(665	)
Ending Balance - December 31, 2016	$	1,528	$	696		$	2,047	$	4,271

Included in current liabilities	$	1,528	$	696		$	-	$	2,224
Included in long-term liabilities	$	-	$	-		$	2,047	$	2,047

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

Note 15 - Stock Compensation Plan (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	December 31,
	2016			2015			2014

Expected volatility	56.48%	-	115.39%	84.19%	-	168.46%	157.24%	-	179.87%
Expected dividends		-			-			-
Expected term (in years)	1.00	-	6.32	0.73	-	6.32	5.50	-	7.50
Risk-free rate	0.76%	-	2.13%	0.39%	-	1.96%	1.65%	-	2.22%

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
								(in thousands)
Options outstanding at December 31, 2014		27,540,899			0.21
Granted		20,285,001			0.14
Exercised		(166,666	)		0.08
Forfeited		(4,933,500	)		0.18
Expired		(815,000	)		0.64
Options outstanding at December 31, 2015		41,910,734			0.21
Granted		23,064,401			0.10
Exercised		(2,197,199	)		0.09
Forfeited		(12,931,033	)		0.14
Expired		(2,264,501	)		0.19
Options outstanding at December 31, 2016		47,582,402		$	0.15		7.4	$	3,669
Options exercisable at December 31, 2016		22,419,208		$	0.17		6.1	$	1,504
Options unvested at December 31, 2016		25,163,194		$	0.14		8.5	$	2,165
Options vested or expected to vest at December 31, 2016		44,423,120		$	0.15		7.3	$	3,379

Schedule of Supplemental Stock Option Data [Table Text Block]

	December 31,
	2016		2015		2014

Weighted average grant date fair value per option granted	$	0.08	$	0.12	$	0.28
Fair value of options vested		2,022		1,584		385
Cash from participants to exercise stock options		206		13		205
Intrinsic value of options exercised		221		8		385

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Options Outstanding									Options Exercisable
Range of Exercise Prices			Numbers of Options Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price

$0.00	-	0.10		20,603,777		7.28	$	0.07		8,132,001		4.97	$	0.08
0.11	-	0.772		26,978,625		7.40		0.21		14,287,207		6.76		0.22

Total				47,582,402						22,419,208

Note 16 - Income Taxes (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	Years Ended December 31,
	2016			2015

Loss carry forwards	$	57,097		$	53,693
Derivative valuations		685			(955	)
NQSO		2,214			1,710
Tax Credits		433			433
Other		(99	)		198
Total deferred tax asset		60,330			55,079

Valuation allowance		(60,330	)		(55,079	)
Total deferred tax asset, net		-			-

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Years Ended December 31,
	2016			2015			2014

Expected federal tax benefit		-34.0	%		-34.0	%		-34.0	%
Permanent items		5.6	%		0.4	%		0.1	%
Net operating loss utilized or expired		0.0	%		0.0	%		0.0	%
Increase in valuation allowance and others		28.4	%		33.6	%		33.9	%

Effective tax rate		0	%		0	%		0	%

Note 23 - Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2016

Quarterly Financial Information [Table Text Block]

	Quarter Ended
	March 31, 2016			June 30, 2016			September 30, 2016			December 31, 2016			Total

Revenue	$	168		$	34		$	154		$	124		$	480
Gross profit (loss)		10			21			(11	)		(93	)	$	(73	)
Operating loss		(2,566	)		(2,367	)		(2,238	)		(2,716	)	$	(9,887	)
Net loss and comprehensive loss		(9,178	)		(824	)		(3,802	)		(4,948	)	$	(18,752	)
Basic and diluted net loss per common share	$	(0.02	)	$	(0.00	)	$	(0.01	)	$	(0.00	)	$	(0.03	)

	Quarter Ended
	March 31, 2015			June 30, 2015			September 30, 2015			December 31, 2015			Total

Revenue	$	26		$	39		$	42		$	18		$	125
Gross profit (loss)		7			(94	)		(118	)		(19	)	$	(224	)
Operating loss		(2,327	)		(2,440	)		(2,372	)		(2,142	)	$	(9,281	)
Net loss and comprehensive loss		(2,480	)		(2,085	)		(1,230	)		(1,522	)	$	(7,317	)
Basic and diluted net loss per common share	$	(0.01	)	$	(0.01	)	$	(0.00	)	$	(0.00	)	$	(0.02	)

Note 2 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Accounts Receivable, Gross, Current	$ 95,000	$ 30,000
Advertising Expense	83,000	76,000	$ 252,000
Interest Paid	9,000	4,000	0
Cash Equivalents, at Carrying Value	0	0
Allowance for Doubtful Accounts Receivable, Current	0	0
Impairment of Long-Lived Assets Held-for-use	0	0	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	$ 0	0	$ 0
Minimum [Member]
Property, Plant and Equipment, Useful Life	1 year
Finite-Lived Intangible Asset, Useful Life	10 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	5 years
Finite-Lived Intangible Asset, Useful Life	17 years
Customer Concentration Risk [Member] \| Two Major Customers [Member]
Accounts Receivable, Gross, Current	$ 95,000	$ 30,000
Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Number of Major Customers	2	3
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Two Major Customers [Member]
Concentration Risk, Percentage	100.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Three Major Customers [Member]
Concentration Risk, Percentage		100.00%
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Number of Major Customers	3	3	4
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member] \| Three Major Customers [Member]
Concentration Risk, Percentage	73.00%	52.00%
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member] \| Four Major Customers [Member]
Concentration Risk, Percentage			84.00%

Note 2 - Summary of Significant Accounting Policies - Fair Value of Items Measured on a Recurring Basis (Details) - Warrant [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Derivative Liability, Current	$ 2,224	$ 0
Derivative Liability, Noncurrent	2,047	59
Fair Value, Measurements, Recurring [Member]
Derivative Liability, Current	2,224
Derivative Liability, Noncurrent	2,047	59
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Derivative Liability, Current	2,224
Derivative Liability, Noncurrent	2,047	59
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.

Note 3 - Significant Transactions (Details Textual) - USD ($)					1 Months Ended		9 Months Ended	12 Months Ended			16 Months Ended
	Oct. 26, 2016	Mar. 10, 2016	Nov. 08, 2013	Jul. 17, 2013	Feb. 28, 2015	Aug. 20, 2014	Sep. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Jul. 02, 2012	Jun. 02, 2012
Common Stock, Par or Stated Value Per Share								$ 0.001	$ 0.001		$ 0.001
Proceeds from Issuance of Common Stock								$ 62,650,000	$ 1,568,000	$ 16,000,000
Interest Expense								$ 9,000	$ 4,000
Liquidmetal Golf [Member]
Noncontrolling Interest, Ownership Percentage by Parent								79.00%
Engel [Member]
Supply and License Agreement, Term								5 years
Exclusive License Agreement, Term								10 years
Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 2,000,000
Line of Credit Facility, Interest Rate During Period					2.10%				2.10%
Interest Expense								$ 9,000	$ 4,000	$ 0
Line of Credit [Member] \| Collateral Pledged [Member] \| Cash [Member]
Line of Credit Facility, Collateral Fees, Amount					$ 1,000,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues								405,000,000	12,500,000	85,355,615
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors		405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors		$ 63,400,000
Stock Issued During Period, Shares, New Issues	300,000,000	105,000,000
Stock Issued During Period, Value, New Issues	$ 55,000,000	$ 8,400,000
Sale of Stock, Price Per Share		$ 0.08
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions	$ 0.15							$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions	$ 0.25							$ 0.25
Common Stock Purchase Agreement, Value of Shares Authorized to Be Purchased No Later than 90 Days after Satisfaction of Certain Conditions	$ 55,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.07
The 2016 Purchase Agreement [Member] \| Shares of Common Stock Vested [Member] \| Vest on March 10, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,609,913
The 2016 Purchase Agreement [Member] \| Shares of Common Stock Vested [Member] \| Vest on October 26, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		7,456,896
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.15 [Member]
Stock Issued During Period, Shares, New Issues	200,000,000
Sale of Stock, Price Per Share	$ 0.15
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions	200,000,000							200,000,000
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.25 [ Member]
Stock Issued During Period, Shares, New Issues	100,000,000
Sale of Stock, Price Per Share	$ 0.25
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions	100,000,000							100,000,000
The 2014 Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors						$ 30,000,000
Stock Issued During Period, Shares, New Issues							12,500,000
Common Stock, Par or Stated Value Per Share						$ 0.001
Common Stock Subscriptions, Term						3 years
Proceeds from Issuance of Common Stock							$ 1,568,000				$ 1,568,000
The 2014 Purchase Agreement [Member] \| Common Stock [Member]
Stock Issued During Period, Shares, New Issues											12,500,000
Stock Issued During Period, Weighted Average Price Per Share							$ 0.13				$ 0.13
Common Stock Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors			$ 20,000,000
Stock Issued During Period, Shares, New Issues										85,355,615
Stock Issued During Period, Value, New Issues										$ 16,000,000
Stock Issued During Period, Shares, Other			2,666,667
Common Stock Purchase Agreement [Member] \| Weighted Average [Member]
Share Price										$ 0.19
Stock Purchase Agreement 2013 [Member]
Common Stock Subscriptions, Term			3 years
Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								10,540,750				18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 0.17	$ 0.19		$ 0.19	$ 0.384
Private Placement [Member] \| Visser MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								21,317,094					15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 0.16					$ 0.22
Private Placement [Member] \| Convertible Notes Payable [Member]
Debt Instrument, Face Amount												$ 12,000,000
Debt Instrument, Convertible, Conversion Price												$ 0.352
Debt Instrument, Interest Rate, Stated Percentage												8.00%
Private Placement [Member] \| Senior Convertible Notes [Member]
Debt Conversion, Converted Instrument, Shares Issued				163,641,547
Private Placement [Member] \| Senior Convertible Notes [Member] \| Weighted Average [Member]
Debt Instrument, Convertible, Conversion Price				$ 0.0774

Note 4 - Trade Accounts Receivable - Trade Accounts Receivable Table (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Trade accounts receivable	$ 95,000	$ 30,000
Less: Allowance for doubtful accounts	0	0
Trade accounts receivable, net	$ 95,000	$ 30,000

Note 5 - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Prepaid service invoices	$ 65	$ 48
Prepaid manufacturing and mold costs	27	118
Prepaid insurance premiums	220	192
Other receivables		50
Total	$ 312	$ 408

Note 6 - Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Raw materials	$ 350	$ 39
Work in progress	25
Finished goods	15	44
Total	$ 390	$ 83

Note 7 - Property and Equipment - Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Property and equipment, gross	$ 3,525	$ 3,327
Accumulated depreciation	(2,386)	(1,957)
Total property and equipment, net	1,139	1,370
Machinery and Equipment [Member]
Property and equipment, gross	2,725	2,545
Computer Equipment [Member]
Property and equipment, gross	236	218
Office Equipment, Furnishings and Improvements [Member]
Property and equipment, gross	$ 564	$ 564

Note 8 - Patents and Trademarks, Net - Patents and Trademarks (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Intangible assets, gross	$ 2,400	$ 2,378
Accumulated amortization	(1,906)	(1,808)
	494	570
Purchased and Licensed Patent Rights [Member]
Intangible assets, gross	566	566
Accumulated amortization	(534)	(517)
Internally Developed Patents [Member]
Intangible assets, gross	1,686	1,664
Accumulated amortization	(1,253)	(1,177)
Trademarks [Member]
Intangible assets, gross	148	148
Accumulated amortization	$ (119)	$ (114)

Note 8 - Patents and Trademarks, Net - Estimated Future Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
2017	$ 86
2018	86
2019	84
2020	81
2021	56
Thereafter	101
	$ 494	$ 570

Note 9 - Short-term Debt (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
Note 9 - Short-term Debt (Details Textual) - USD ($)	Feb. 28, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Short-term Debt		$ 0	$ 700,000
Interest Expense		9,000	4,000
Line of Credit [Member]
Short-term Debt		0	$ 700,000
Line of Credit Facility, Interest Rate During Period	2.10%		2.10%
Interest Expense		$ 9,000	$ 4,000	$ 0

Note 10 - Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Accrued payroll, vacation, and bonuses	$ 606	$ 766
Accrued severance	301
Accrued audit fees	72	109
Straight-line rent accruals	91	72
Total	$ 1,070	$ 947

Note 11 - Warrant Liabilities (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Mar. 10, 2016	Jul. 02, 2012	Jun. 30, 2012
Fair Value Assumptions, Risk Free Interest Rate			1.10%
Fair Value Assumptions, Expected Dividend Rate		0.00%	0.00%
Fair Value Adjustment of Warrants		$ 4,117,000	$ (1,946,000)	$ (2,700,000)
Class of Warrant or Right, Outstanding	41,924,653	41,924,653	36,509,931
Common Stock [Member]
Stock Issued During Period, Shares, Warrants Exercised in Period		1,743,480		1,178,000
Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	10,540,750	10,540,750				18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.17	$ 0.17	$ 0.19			$ 0.384
Fair Value Adjustment of Warrants		$ 1,336,000	$ (927,000)	$ (1,194,000)
Class Of Warrant Or Right Exercised in Period	7,031,250
Stock Issued During Period, Shares, Warrants Exercised in Period	1,743,480
Decrease in Warrant Liability, Warrants Exercised	$ 665,000
Private Placement [Member] \| Common Stock [Member]
Stock Issued During Period, Value, Warrants Exercised in Period	2,000
Private Placement [Member] \| Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Warrants Exercised in Period	663,000
The 2016 Purchase Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.07
Fair Value Adjustment of Warrants		(1,287,000)	0	0
The 2016 Purchase Agreement [Member] \| Warrants Valued as Liability [Member]
Derivative Liability, Noncurrent					$ 760,000
Warrant [Member]
Derivative Liability, Noncurrent	2,047,000	2,047,000	59,000
Derivative Liability	4,271,000	4,271,000	59,000
Fair Value Adjustment of Warrants		4,117,000
Decrease in Warrant Liability, Warrants Exercised		665,000
Warrant [Member] \| Private Placement [Member]
Derivative Liability, Noncurrent						$ 5,053,000
Derivative Liability	696,000	$ 696,000	25,000
Fair Value Assumptions, Expected Term		182 days
Fair Value Assumptions, Expected Volatility Rate		76.00%
Fair Value Assumptions, Risk Free Interest Rate		0.60%
Fair Value Assumptions, Expected Dividend Rate		0.00%
Fair Value Adjustment of Warrants		$ 1,336,000
Decrease in Warrant Liability, Warrants Exercised		665,000
Warrant [Member] \| The 2016 Purchase Agreement [Member]
Derivative Liability, Noncurrent	2,047,000	2,047,000
Derivative Liability	$ 2,047,000	$ 2,047,000
Fair Value Assumptions, Expected Term		9 years 69 days
Fair Value Assumptions, Expected Volatility Rate		122.00%
Fair Value Assumptions, Risk Free Interest Rate		2.50%
Fair Value Assumptions, Expected Dividend Rate		0.00%
Fair Value Adjustment of Warrants		$ 1,287,000
Decrease in Warrant Liability, Warrants Exercised
Visser MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	21,317,094	21,317,094	18,937,931				15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.16	$ 0.16	$ 0.17				$ 0.22
Derivative Liability, Noncurrent							$ 4,260,000
Fair Value Adjustment of Warrants		$ 1,494,000	$ (1,019,000)	$ (1,506,000)
Visser MTA Agreement [Member] \| Warrant [Member]
Derivative Liability	$ 1,528,000	$ 1,528,000
Fair Value Assumptions, Expected Term		153 days
Fair Value Assumptions, Expected Volatility Rate		82.00%
Fair Value Assumptions, Risk Free Interest Rate		0.60%
Fair Value Assumptions, Expected Dividend Rate		0.00%

Note 11 - Warrant Liabilities - Summary of Changes in Warrant Liabilities (Details) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jul. 02, 2012
Change in value of warrant liability, loss		$ 4,117,000	$ (1,946,000)	$ (2,700,000)
Private Placement [Member]
Change in value of warrant liability, loss		1,336,000	(927,000)	(1,194,000)
Exercises	$ (665,000)
The 2016 Purchase Agreement [Member]
Change in value of warrant liability, loss		(1,287,000)	0	$ 0
Warrant [Member]
Derivative liabilities, balance		59,000
Original valuation- new issuances		760,000
Change in value of warrant liability, loss		4,117,000
Exercises		(665,000)
Derivative liabilities, balance	4,271,000	4,271,000	59,000
Included in current liabilities	2,224,000	2,224,000	0
Included in long-term liabilities	2,047,000	2,047,000	59,000
Warrant [Member] \| Visser MTA Agreement [Member]
Derivative liabilities, balance		34,000
Original valuation- new issuances
Change in value of warrant liability, loss		1,494,000
Exercises
Derivative liabilities, balance	1,528,000	1,528,000	34,000
Included in current liabilities	1,528,000	1,528,000
Included in long-term liabilities
Warrant [Member] \| Private Placement [Member]
Derivative liabilities, balance		25,000
Original valuation- new issuances
Change in value of warrant liability, loss		1,336,000
Exercises		(665,000)
Derivative liabilities, balance	696,000	696,000	25,000
Included in current liabilities	696,000	696,000
Included in long-term liabilities					$ 5,053,000
Warrant [Member] \| The 2016 Purchase Agreement [Member]
Derivative liabilities, balance
Original valuation- new issuances		760,000
Change in value of warrant liability, loss		1,287,000
Exercises
Derivative liabilities, balance	2,047,000	2,047,000
Included in current liabilities
Included in long-term liabilities	$ 2,047,000	$ 2,047,000

Note 11 - Warrant Liabilities - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Risk-free interest rate		1.10%
Dividend rate	0.00%	0.00%
Minimum [Member]
Expected life in years (Year)	153 days	1 year 153 days
Volatility	76.00%	56.00%
Risk-free interest rate	0.60%
Maximum [Member]
Expected life in years (Year)	9 years 69 days	1 year 182 days
Volatility	122.00%	57.00%
Risk-free interest rate	2.50%

Note 11 - Warrant Liabilities - Outstanding Warrants to Acquire Shares of the Common Stock (Details) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Number of shares (in shares)	41,924,653	36,509,931
Warrant 1 [Member]
Number of shares (in shares)	21,317,094
Exercise price (in dollars per share)	$ 0.16
Warrant 2 [Member]
Number of shares (in shares)	10,540,750
Exercise price (in dollars per share)	$ 0.17
Warrant 3 [Member]
Number of shares (in shares)	10,066,809
Exercise price (in dollars per share)	$ 0.07

Note 12 - Option Liabilities (Details Textual) - USD ($) $ / shares in Units, $ in Thousands					12 Months Ended
	Oct. 26, 2016	Aug. 11, 2016	May 19, 2016	Mar. 10, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Original Valuation, Options					$ 511
Fair Value Assumptions, Risk Free Interest Rate						1.10%
Fair Value Assumptions, Expected Dividend Rate					0.00%	0.00%
Fair Value Adjustment of Options					$ 2,613
Gain (Loss) on Contract Modification					(2,126)
The 200 Million Share, Call Option [Member]
Original Valuation, Options					489
Derivative Liability, Current					0	0
Fair Value Adjustment of Options					2,442
The 100 Million Share, Call Option [Member]
Original Valuation, Options					22
Derivative Liability, Current					0	$ 0
Fair Value Adjustment of Options					$ 171
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions	$ 0.15				$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions	$ 0.25				$ 0.25
Common Stock Purchase Agreement, Remaining Number of Shares Required to be Purchased before Forfeiture of RIghts			300,000,000
Gain (Loss) on Contract Modification		$ (2,126)
Stock Issued During Period, Shares, New Issues	300,000,000			105,000,000
The 2016 Purchase Agreement [Member] \| The 200 Million Share, Call Option [Member]
Original Valuation, Options					$ 489
Derivative Liability, Current			$ 2,931
Fair Value Adjustment of Options					2,442
The 2016 Purchase Agreement [Member] \| The 100 Million Share, Call Option [Member]
Original Valuation, Options					22
Derivative Liability, Current			$ 193
Fair Value Adjustment of Options					$ 171
The 2016 Purchase Agreement [Member] \| Call Option [Member]
Fair Value Assumptions, Expected Term			91 days
Fair Value Assumptions, Expected Volatility Rate			85.00%
Fair Value Assumptions, Risk Free Interest Rate			0.31%
Fair Value Assumptions, Expected Dividend Rate			0.00%
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.15 [Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions	200,000,000				200,000,000
Stock Issued During Period, Shares, New Issues	200,000,000
The 2016 Purchase Agreement [Member] \| Common Stock, Purchase Price per Share of $0.25 [ Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions	100,000,000				100,000,000
Stock Issued During Period, Shares, New Issues	100,000,000

Note 12 - Option Liabilities - Summary of the Changes in Option Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Original valuation	$ 511
Loss from change in value of option liabilities	2,613
Reclassification to shareholders' equity	(3,124)
Call Option [Member]
Balance	0
Balance	0	0
The 200 Million Share, Call Option [Member]
Balance	0
Original valuation	489
Loss from change in value of option liabilities	2,442
Reclassification to shareholders' equity	(2,931)
Balance	0	0
The 100 Million Share, Call Option [Member]
Balance	0
Original valuation	22
Loss from change in value of option liabilities	171
Reclassification to shareholders' equity	(193)
Balance	$ 0	$ 0